Series B and Seed Rounds Fuel AI Health Platforms, Robotics Foundations and Clinical Data Infrastructure
Recent funding rounds across AI, robotics and biology bring capital to revenue‑assurance AI, lab‑digitisation, agentic AI, robot foundation models, humanoid robotics and global clinical data networks.
Compiled automatically from the sources listed below and checked against Hyperuranios' own capital and research data. Every figure here traces to a linked source. Factual errors reported to the contact address are corrected in the article and noted here.
Artificial Intelligence
Arintra closed a $25 million Series B round to expand its AI‑driven revenue‑assurance platform for health‑system RCM. Define Ventures led the round with participation from existing backers including Peak XV Partners, YNHH Center for Health Care Innovation, Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Ten13 and Spider Capital. The company will use the capital to broaden its platform, add clinical and specialty coverage and scale across more enterprise health systems, citing a 5.1 % lift in compliant revenue capture and a 43 % drop in coding‑related denials [1].
Transfyr raised $25 million in a seed round to digitise bench‑level laboratory work. General Catalyst led the round, with Lux Capital, Breakout Ventures, Factory, Neo, SV Angel, MVP Ventures, Underscore VC, Lyda Hill and angel investors also participating. The Cambridge‑based startup builds sensor arrays and AI models that capture tacit lab actions, turning them into data for reproducibility, protocol optimisation and robot‑readable instructions, and is hiring engineers and AI researchers to scale the platform [2].
Runable secured $21 million in a Series A co‑led by Susquehanna Venture Capital and Nexus Venture Partners, valuing the Bengaluru startup at $65 million post‑money. Existing investors Together Fund and Array VC also participated. The funding will fuel growth channels, improve campaign measurement and extend its autonomous AI agents that build websites, apps and manage advertising, sales and support for small businesses. Runable reports 1.5‑1.7 million users, $2 million ARR within three weeks of launch, and plans to expand its free Runable Academy and hire across engineering, ML, product and growth functions [8][9].
Robotics
Generalist announced an extension of its Series B with nearly $200 million of new capital, pushing the round’s total to $600 million and lifting its post‑money valuation to $3 billion. The extension was led by 8VC, following a June $400 million raise led by Radical Ventures. Founded by ex‑DeepMind researchers Pete Florence and Andy Zeng and former Boston Dynamics engineer Andrew Barry, Generalist is developing a foundation model—Gen 1.5—that enables robots to learn new tasks from 3‑12‑second video clips and to generalise across hardware platforms, currently working with a small set of customers to tailor the technology [3][4][5][6][7].
XPENG’s robotics unit raised more than $900 million in a private round that values the business at over $6.3 billion. The round was led by IDG Capital with participation from Gaorong Ventures and strategic investors Tencent and Alibaba. Proceeds will accelerate software and hardware R&D, generate high‑quality training data and build mass‑production facilities for the IRON humanoid platform, which features 76 degrees of freedom, three Turing AI chips delivering 2,250 TOPS and a flexible lattice structure, with mass production slated for the end of 2026 and global deployments beginning in 2027 [11].
Vertex Ventures China, backed by Temasek, outlined a strategy for Chinese robotics startups to reach the U.S. market by establishing operations in Singapore after the U.S. ban on foreign‑made humanoid robots. Managing partner Choon Chong Tay said Singapore‑based entities can control critical components and meet transformation rules, enabling firms such as Unitree Robotics, Horizon Robotics, Geek+, Edge Medical and Lightelligence to continue exporting to the United States. Vertex manages nearly $3 billion across funds and views physical‑AI as a decade‑long growth theme [10]. [9]
Genetic Engineering
OmicsBank closed a $2.25 million seed round from Redesign Health to fund its expansion into the United States and grow its clinical data network across Asia and the Middle East. Founded in 2025, the platform now aggregates longitudinal EHR data from 12.5 million patients, over 30 million DICOM images, 6 million pathology slides and 500 000 genome sequences, and is building GPU‑enabled environments for AI model training, reinforcement learning and biomarker discovery [1]. [9]
MaxQ Medical raised $31.5 million in a Series A round led by Atlantic Blue Ventures, S3 Ventures and Olympus Innovation Ventures, with participation from Hillside Capital. The capital will be used to expand the team and advance clinical trials for its all‑in‑one transurethral imaging and therapy system targeting benign prostate hyperplasia, with later plans to address focal therapy for prostate cancer and broader diagnostic applications [1].